News

Win a Compatibility Study For Injectable Products 

Construction of a New Industrial Facility in Gannat

UNITHER invests 68 million euros in the innovative project: Euroject®

Official launch of the CURECALL solution to ophthalmologists in France!

Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division

Using Differentiated Drug-Delivery Technologies to Deliver Competitive Advantages

Rare Disease Day

Advancing ophthalmology: Unither invests in its French R&D site.

Development of a new prophylactic vaccine

Successful completion of the sale of the Carragelose business

Press Release – Acquisition of the Carragelose Portfolio by Unither Pharmaceuticals

BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage